Twist Bioscience Corporation
TWST
$55.95
-$0.26-0.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.77% | 4.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.77% | 4.74% | |||
| Cost of Revenue | 7.78% | 3.23% | |||
| Gross Profit | 5.84% | 6.17% | |||
| SG&A Expenses | 9.09% | 9.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.35% | 5.94% | |||
| Operating Income | -17.50% | -9.91% | |||
| Income Before Tax | -45.36% | -12.55% | |||
| Income Tax Expenses | -83.00% | -1.56% | |||
| Earnings from Continuing Operations | -44.30% | -12.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -44.30% | -12.41% | |||
| EBIT | -17.50% | -9.91% | |||
| EBITDA | -20.14% | -0.66% | |||
| EPS Basic | -42.82% | -11.22% | |||
| Normalized Basic EPS | -20.32% | -11.37% | |||
| EPS Diluted | -42.82% | -11.22% | |||
| Normalized Diluted EPS | -20.32% | -11.37% | |||
| Average Basic Shares Outstanding | 1.02% | 1.09% | |||
| Average Diluted Shares Outstanding | 1.02% | 1.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||